Brainlab, Inc.
$119.2K 382 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Neptune Medical Inc.
Neptune Medical Inc. reported $119,448.66 across General Payments, Research, and Ownership to 49 physicians and teaching hospitals across 49 transactions.
- $119.4K Below-median payer
- All-tracks total
- 49 Below-median volume
- Transactions
- 49 Below-median reach
- Recipients
- +$54.1K
- General Payments vs PY2023
Neptune Medical Inc. reported $119,448.66 across all CMS Open Payments tracks (General + Research + Ownership) to 49 physicians and teaching hospitals in Program Year 2024 - ranking #1138 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $119,448.66, averaging $2.4K per recipient.
Neptune Medical Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer neptune-medical-inc Neptune Medical Inc.
$119.4K · #1138/1,925 · 0.0% industry · PY2024
- TOT $119.4K
- RANK #1138
- SHARE 0.0%
- TXN 49
- RCP 49
- CAT 2
- GEN $119.4K
- ΔGEN +$54.1K
- TOP1 17.3%
- PY 2024
Volume peers
Nearest volume peer: Brainlab, Inc. ($119.2K)
Neptune Medical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Neptune Medical Inc.'s CMS-reported General Payments increased by $54.1K (+82.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: NEPTUNE MEDICAL INC.PY2024: Neptune Medical Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $65,367.04
- PY2024
- $119,448.66
What the Data Shows for Neptune Medical Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Neptune Medical Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $116.8K across 43 transactions, 97.8% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, Neptune Medical Inc.'s largest category was "Consulting Fee" at $116.8K - 97.8% of General Payments.
How Neptune Medical Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $116.8K | 43 | 97.8% |
| Travel and Lodging | $2.6K | 6 | 2.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $71,500.00 (59.9%) of $119,448.66 in this company's General Payments records across 24 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Neptune Medical Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Jason Samarasena
$20,700.00 across 4 reported transactions
- 2
Joshua Goldberg
$18,000.00 across 3 reported transactions
- 3
Amandeep Shergill
$13,600.00 across 4 reported transactions
- 4
Drew Schembre
$11,600.00 across 3 reported transactions
- 5
Mike Wei
$7,600.00 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Neptune Medical Inc.'s spend rank (#1138 of 1,925, bottom 41% by spend) and concentration rank (#1,052 of 1,838, bottom 43% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Cytyc Surgical Products, LLC : $12.4K total payments, HHI 961
- BioXcel Therapeutics, Inc. : $116.0K total payments, HHI 958
- Spinefrontier, Inc. : $26.7K total payments, HHI 958
- PARI Respiratory Equipment, Inc. : $262.70 total payments, HHI 954
- Rayner Intraocular Lenses Limited : $262.7K total payments, HHI 950
- STRATA Skin Sciences, Inc. : $89.3K total payments, HHI 940
- Neptune Medical Inc. (this company) : $119.4K total payments, HHI 936
- Spirair, Inc. : $58.8K total payments, HHI 936
- Neoss, Inc. : $107.6K total payments, HHI 934
- Acist Medical Systems, Inc. : $163.3K total payments, HHI 931
- USA Angelalign Technology Corp : $100.0K total payments, HHI 930
- IntrinsiQ Specialty Solutions, Inc. : $1.3K total payments, HHI 926
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Neptune Medical Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Neptune Medical Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Neptune Medical Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
NuMED for Children, LLC
$120.0K 4 recipients
Compare payment profiles
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)
$120.0K 15 recipients
Compare payment profiles
Aurobindo Pharma USA, Inc.
$120.1K 137 recipients
Compare payment profiles
Human Regenerative Technologies
$118.8K 60 recipients
Compare payment profiles
CorMedix Inc.
$120.2K 1,060 recipients
Compare payment profiles
Put this to use
Neptune Medical Inc. ranks #1138 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Neptune Medical Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.